Levonicopto (Levofloxacin)

Levonicopto, a fluoroquinolone ophthalmic antibacterial, is used to manage bacterial infections of the eye.

• Bacterial conjunctivitis: reduces bacterial load and accelerates resolution of infection.
• Keratitis: eradicates causative bacteria and promotes corneal healing.
• Other ocular bacterial infections: treats bacterial blepharitis, dacryocystitis, and postoperative ocular infections.

• Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to the ATP‑binding sites of these enzymes, it prevents supercoiling and separation of DNA strands, leading to bacterial cell death. The drug exhibits broad‑spectrum activity against Gram‑negative and Gram‑positive ocular pathogens, providing bactericidal action when applied topically to the eye.

Levonicopto may cause ocular and systemic adverse reactions, which are generally mild but can be serious in rare cases.

Common Side Effects

• Eye irritation: transient burning or stinging upon instillation.
• Redness: conjunctival hyperemia.
• Foreign body sensation: feeling of grit in the eye.
• Increased tearing: lacrimation.

Serious or Rare Side Effects

• Corneal ulceration: worsening of corneal integrity.
• Allergic reaction: swelling, itching, or rash around the eye.
• Systemic hypersensitivity: fever, chills, or anaphylaxis.

When prescribing Levonicopto, clinicians should consider several safety and handling precautions.

• Contraindication: avoid use in patients with known hypersensitivity to levofloxacin or other fluoroquinolones.
• Caution in corneal disease: monitor closely in patients with pre‑existing corneal epithelial defects.
• Pregnancy and lactation: use only if the potential benefit outweighs the risk, as safety data are limited.
• Contact lens wearers: advise removal of lenses before instillation and delay reinsertion until the eye is dry.
• Drug interactions: be aware of potential reduced efficacy when used with topical corticosteroids.
• Store at room temperature: keep the solution below 25 °C, protect from light and moisture, and retain in the original container.

Levonicopto can interact with other ophthalmic agents and systemic medications.

Major Interactions (Avoid)

• Concurrent fluoroquinolone therapy: may increase risk of tendon toxicity and systemic fluoroquinolone exposure.
• Topical corticosteroids: can diminish antibacterial effect and increase risk of secondary infection.

Moderate Interactions (Monitor Closely)

• Anticholinergic eye drops: may affect ocular surface tolerance.
• Systemic NSAIDs: monitor for additive ocular irritation.
• Herbal supplements containing quinine: potential additive QT prolongation risk.